...
机译:每周紫杉醇和心肺素治疗同期化学疗法的II期试验,晚食管癌
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Shanghai Canc Ctr Dept Radiat Oncol Minhang Branch 106RuiLi Rd Shanghai 200240;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Ernst von Bergmann Med Ctr Dept Clin Radiat Oncol D-14467 Potsdam Germany;
Fudan Univ Dept Radiat Oncol Shanghai Canc Ctr 270 DongAn Rd Shanghai 200032 Peoples R China;
Oesophageal carcinoma; Paclitaxel; Carboplatin; Chemoradiotherapy;
机译:每周紫杉醇和心肺素治疗同期化学疗法的II期试验,晚食管癌
机译:每周紫杉醇和卡铂同时放化疗治疗局部晚期头颈癌:布朗大学肿瘤学组II期研究(HN-53)的长期随访。
机译:II期研究评估在头颈部局部晚期鳞状细胞癌患者每周卡铂,紫杉醇和每日放疗的同时分娩中添加西妥昔单抗
机译:I / II期临床试验关于每周紫杉醇(WPTX)和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:每周一次紫杉醇联合卡铂联合放化疗治疗晚期食管癌的Ⅱ期试验
机译:同步放化疗联合每周紫杉醇和5-氟尿嘧啶方案治疗晚期食管癌的II期研究